CONTENTS

• LIST OF TABLES AND FIGURES
• INTRODUCTION
• CAUSE OF THE DISEASE
• RISK FACTORS & PREVENTION
• DIAGNOSIS OF THE DISEASE
• VARIATION BY GEOGRAPHY/ETHNICITY
• DISEASE PROGNOSIS & CLINICAL COURSE
• KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
• METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
• TOP-LINE PREVALENCE FOR CHRONIC HEART FAILURE
• CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
• FEATURES OF CHF-REF PATIENTS
• COMORBID CONDITIONS OF CHF-REF PATIENTS
• CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
• FEATURES OF CHF-PEF PATIENTS
• COMORBID CONDITIONS OF CHF-PEF PATIENTS
• ABBREVIATIONS USED IN THE REPORT
• OTHER BLACK SWAN ANALYSIS PUBLICATIONS
• BLACK SWAN ANALYSIS ONLINE PATIENT-BASED DATABASES
• PATIENT-BASED OFFERING
• ONLINE PRICING DATA & PLATFORMS
• REFERENCES
• APPENDIX

LIST OF TABLES AND FIGURES
• Table 1. Aetiologies of Heart Failure
• Table 2. Symptoms and Signs Typical of Heart Failure
• Table 3. Classification and Common Clinical Characteristics of Patients with Acute Heart Failure
• Table 4. NYHA Classification of Heart Failure
• Table 5. Clinical-hemodynamic Profiles of Heart Failure (following Stevenson et al)
• Table 6. Markers of Worse Prognosis in Patients with Heart Failure
• Table 7. Prevalence of Chronic Heart Failure, total (000s)
• Table 8. Prevalence of Chronic Heart Failure, males (000s)
• Table 9. Prevalence of Chronic Heart Failure, females (000s)
• Table 10. Prevalence of CHF-REF, total (000s)
• Table 11. Prevalence of CHF-REF, males (000s)
• Table 12. Prevalence of CHF-REF, females (000s)
• Table 13. CHF-REF Patients by NYHA Class, total (000s)
• Table 14. CHF-REF Patients with Diabetes, total (000s)
• Table 15. CHF-REF Patients with COPD, total (000s)
• Table 16. CHF-REF Patients with Anaemia, total (000s)
• Table 17. CHF-REF Patients with Atrial Fibrillation, total (000s)
• Table 18. CHF-REF Patients with Coronary Artery Disease, total (000s)
• Table 19. CHF-REF Patients with previous Myocardial Infarction, total (000s)
• Table 20. CHF-REF Patients with Muscle Wasting, total (000s)
• Table 21. Prevalence of CHF-PEF, total (000s)
• Table 22. Prevalence of CHF-PEF, males (000s)
• Table 23. Prevalence of CHF-PEF, females (000s)
• Table 24. CHF-PEF Patients by NYHA Class, total (000s)
• Table 25. CHF-PEF Patients with Diabetes, total (000s)
• Table 26. CHF-PEF Patients with COPD, total (000s)
• Table 27. CHF-PEF Patients with Anaemia, total (000s)
• Table 28. CHF-PEF Patients with Atrial Fibrillation, total (000s)
• Table 29. CHF-PEF Patients with Coronary Artery Disease, total (000s)
• Table 30. CHF-PEF Patients with previous Myocardial Infarction, total (000s)
• Table 31. CHF-PEF Patients with Muscle Wasting, total (000s)
• Table 32. Abbreviations and Acronyms used in the report
• Table 33. USA Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 34. USA Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 35. Canada Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 36. Canada Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 37. France Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 38. France Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 39. Germany Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 40. Germany Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 41. Italy Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 42. Italy Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 43. Spain Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 44. Spain Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 45. UK Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 46. UK Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 47. Japan Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 48. Japan Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 49. China Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 50. China Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 51. Russia Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 52. Russia Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 53. Brazil Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 54. Brazil Prevalence of CHF by 5-yr age cohort, females (000s)
• Table 55. India Prevalence of CHF by 5-yr age cohort, males (000s)
• Table 56. India Prevalence of CHF by 5-yr age cohort, females (000s)